Final Year MB CHB Revision Haematology: DR M Drummond Cons Haem, GGH & Boc
Final Year MB CHB Revision Haematology: DR M Drummond Cons Haem, GGH & Boc
Final Year MB CHB Revision Haematology: DR M Drummond Cons Haem, GGH & Boc
Lecture
Haematology
Dr M Drummond
Cons Haem, GGH & BOC
Topics
In no particular order……
Malignancy
Haem Malignancy
• History is crucial:
– Wt loss (10% in 6 months)
– Night Sweats
– Fever
Lymphoma
++++ ++++ ++ ++ ++ ++++ +
/ LPDs
Acute
Leukaemia
+ + 0/+ ++++ + 0/+ 0
Myeloma
0/+ ++ 0 ++ 0 0 ++++
MPDs
(Myeloproli
ferative +++ +++ +++ + ++++ 0 0
disorders)
Lymph Node Groups
Lymphadenopathy (1):
• Site
• Size
• Consistency (rubbery vs craggy)
• Tenderness
• Fixed
Lymphadenopathy (2)
• Generalised:
– EBV, CMV, HIV
– Brucellosis, syphilis
– Toxoplasma
– Lymphoma or CLL
– (occasionally CT disease)
• Localised
– Acute or chronic infection
– Neoplasia (cancer, lymphoma)
Splenomegaly (1)
• ULN: 13cm in long axis (USS or CT)
• May occasionally be ‘tippable’ in slim healthy individual
• Causes of splenomegaly in UK (exams)
– Myelofibrosis
– Lymphoma
– Gauchers disease
• Causes of massive splenomagaly in UK:
– Myelofibrosis
– CML (treatment so effective don’t see this in exams)
– (rarely) lymphoma
Splenomagaly (2)
• features:
– Dull to percussion
Spleen Examination 2: line of resonance
Lymphoma
• Cancer of lymphatic system
14
Ann Arbor Staging System
• I = single LN region (I) or single extralymphatic
organ or site (IE)
• II = ≥ 2 LN areas, same side of diaphragm (II) or
with ltd localised EN extension (IIE)
• III = LN areas on both sides of diaphragm (if
includes spleen IIIS)
• IV = extensive disease of ≥1 extralymphatic organ
eg liver, bone marrow
• A/B
• Bulk
15
HL - clinical features
• Asymptomatic LN enlargement (70%)
• Mass on CXR
• Sites
– Neck 60-80%
– Mediastinal ~60%
– Axillae 10-20%
– Inguinal 6-12%
– Infradiaphragmatic ~10%
16
Hodgkin Lymphoma
• Bimodal age distribution
– Peak 20-30’s
– 2nd peak >50 yrs
• Usually arises in LN and spreads to
adjacent LN areas
• Later, haematogenous spread to liver,
lungs
HL - clinical features
• B symptoms
– unexplained fever >38 degrees
– night sweats
– weight loss >10% body wt in 6 months
• generalised pruritis
• alcohol induced LN pain
– <10% but highly specific
18
Hodgkin
Lymphoma
CT Chest at
diagnosis
Mediastinal
mass
CT
post treatment
with chemotx.
And radiotherapy
Complete
remission
Non Hodgkins Lymphoma
B cell T cell
Multiple
lytic
lesions in
skull and
humerus
Leukaemia Classification
Myeloid
Acute
Leukaemia lymphoid
Chronic
Myeloid
Cases/100,000
Majority of cases occur in later life.
Treatable but in most cases not
curable.
• Potentially curable
• ALL vs AML
Symptom
Distribution
in haem Sweats / Marrow Splenom Lymphad Bone
Wt loss Itch
malignancy
fever Failure egaly enopathy Disease
Lymphoma
++++ ++++ ++ ++ ++ ++++ +
/ LPDs
Acute
Leukaemia
+ + 0/+ ++++ + 0/+ 0
Myeloma
0/+ ++ 0 ++ 0 0 ++++
MPDs
(Myeloproli
ferative +++ +++ +++ + ++++ 0 0
disorders)
Malignancy
• Neutropaenic Sepsis
– ? Likely – most chemotherapy regimens neutrophils
down by day 8-10
– Rapid assessment necessary
– Culture
– Don’t delay for CXR etc
• Koilonychia, glossitis
• Jaundice
• Lymphadenopathy / hepatosplenomegaly
• PR & FOB testing
Ferritin
• Serum ferritin correlates well with liver and
macrophage stores
• N range 15-300 ug/ml
• Mean adult male level: 100; mean adult
premenopausal female level 30.
• <15, specific for depletion of iron stores; normal
values do not exclude this!! Values >300 are not
usually indicative of iron overload (Acute Phase
Reactant)!!
• Use of BM for iron stores
• Ferritin <50 cw absent stores in RA, IBD
Assessing iron status
• IDA: ferritin Lo (absent on BM); TIBC Hi, Serum
transferrin satn (STS) Lo (<15%);
Hb: 8
MCV: 65
WBC: 5
Plts: 150
ESR: 5
Case 1 Female 18yrs
Case 1 Female 18yrs
Film: oval
macrocytes,
hypersegmented
neutrophils
Diagnosis: severe megaloblastic anaemia
May see some megaloblastic change in the context of certain drugs (eg
methotrexate, azathioprine) or alcohol.
Clinical Features
• Common: Pancytopaenia
Glossitis
Diarrhoea
PV discomfort
Hb: 7.6
MCV: 128
WBC: 14
Plts: 326
ESR: 5
Case: Male 28yrs
Case Male 28yrs
• Non-immune
» Infection (malaria, clos, perfringens, septicaemia etc)
» Chemical / physical agents (burns, lead poisoning etc)
» Mechanical injury (heart valves, MAHA etc)
» Acquired membrane disorders (eg liver disease, PNH)
Haemolytic Anaemia
• Laboratory features
• Anaemia: polychromasia; spherocytes (HS,
AIHA); fragments (MAHA)
• Reticulocytosis
• Raised bilirubin (generally 30-50)
• Raised LDH
• Absent haptoglobins
• Folic Acid Deficiency (chronic HA, acute
aggravation)
• Iron Deficiency (Chronic IV haemolysis;
increased urinary haemosiderin but not in EV
haemolysis)
Clotting
Over anticoagulation
APTT
Clotting Cascade PT
XI
IX
Final Common Pathway
VIII
X
PS/aPC V
II (prothrombin)
I (fibrinogen)
Clot (fibrin)
Clotting Disorders
Inherited Acquired
Haem A
N N N N N
Haem B
N N N N N
vWD
N /N N /N N N
DIC
warfarin N/ N N N N
Clinical Bleeding
• Platelet disorders (eg aspirin, thrombocytopaenia
– Mucocutaneous
• Commencing warfarin:
– Proteins C & S (natural anticoagulants) are Vit K
dependent
– Initial fall can promote thrombosis
– Therefore cover with heparin (at least 4 days and
for 2 days with therapeutic INR)
– Particular caution with protein C deficiency:
cautious introduction with heparin & no loading
dose
Over Warfarinisation
Warfarin Guidelines: Brit J Haem, 1998, 101 374-387
palpable vasculitis
Non-palpable thrombocytopaenia
CT disorders
Ecchymotic (>3mm)
Clotting disorder
11 year old boy. ? Other symptoms / signs ?
Purpura in BM failure
• Sites:
– local trauma, lower limbs, under dressings,
clothes (eg bra straps), mouth, but most
important: fundi
• Wet vs Dry purpura
– Avoid aspirin / NSAIDS
– Prophylactic platelet transfusion (threshold 10
– 20)
Thrombocytopaenia
Thrombocytopaenia
• Plt count <150
• Few problems >50
• Most problems <20
• Increased Destruction
– Immune:
» ITP, drugs, infection
– Non-Immune:
» DIC, TTP, Cardiac Bypass.
Hyposplenism
Guidelines for the prevention and treatment of
infection in patients with an absent or dysfunctional
spleen
BMJ 1996; 312; 430 -
434http://www.bcshguidelines.com/pdf/SPLEEN96.pdf
• Encapsulated bacteria:
– Pneumococcus (mortality up to 60% in some cases)
– Haemophilus influenzae type B
– Meningococcus
• Others
– Malaria, E Coli, capnocytophaga canimorsus
Duration of risk: most occur within 2 years, up to a third at least 5 years later, and
some reports of 20 years later!
The risk of dying of serious infection is clinically significant and almost certainly
lifelong!!
Antibiotic Prophylaxis
• Lifelong
– Phenoxymethylpenicillin (plus supply of amoxycillin
to hand)
– Erythromycin in allergic
• Antimalarial prophylaxis
• Prompt treatment (IV penicillin /
cephalosporin)
– Infective symptoms
– Animal bites!! (5 days of augmentin)
• Medic alert bracelets
The End!!
Good Luck!!